Market Size of Pediatric Healthcare Industry
Study Period | 2019 - 2029 |
Market Size (2024) | USD 15.32 Billion |
Market Size (2029) | USD 18.64 Billion |
CAGR (2024 - 2029) | 4.00 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Pediatric Healthcare Market Analysis
The Pediatric Healthcare Market size is estimated at USD 15.32 billion in 2024, and is expected to reach USD 18.64 billion by 2029, growing at a CAGR of 4% during the forecast period (2024-2029).
COVID-19 had significantly impacted the pediatric healthcare market due to the decline in pediatric services during the pandemic. For instance, according to the BMC study published in March 2021, the pandemic and public health restrictions have harmed children's health and mental well-being, which has been exacerbated by the difficulties in obtaining primary and community care. The impact on children with disabilities and chronic health conditions was greater and prompted child protection concerns for vulnerable children. Such studies highlighted the adverse impact of the outbreak on pediatric healthcare in the initial phase of the pandemic, thereby impeding the market growth. However, with the surge in vaccination programs globally and the resumption of pediatric care services and facilities, the market returned to its pre-pandemic levels of growth.
The major factors attributed to the growth of the pediatric healthcare market are a growing burden of diseases, viral infections, and malnutrition cases every year. For instance, according to Observer Research Foundation data published in December 2021, India has nearly 200 million undernourished people. Infectious disorders such as pneumonia, diarrhea, and malaria, as well as premature birth and intrapartum complications, continue to be the primary causes of death among children under the age of five around the world. Such a high burden of deaths creates the need for early proper preventive measures which is expected to drive the growth of the market.
Furthermore, favorable government support such as funding activities, combined with increased technological advancements, fuels the pediatric healthcare market. For instance, in October 2022, French government launched "immediate action plan" along with EUR 150 million (USD 155.4 million) funding for pediatrics. Also, in June 2021, the Finance Ministry in India invested over Rs. 23,220 crore (USD 285.6 million) funding for setting up pediatric facilities in hospitals. Hence, such initiatives are likely to support market growth over the forecast period.
However, the small size of the study population and ethical issues in pediatric research, along with complications associated with medicines in pediatrics, among others, may hinder the market growth.
Pediatric Healthcare Industry Segmentation
As per the scope of this report, pediatric healthcare is a branch of medicine that deals with the medical care, development, and related diseases of infants, children, and adolescents. The pediatric healthcare market grows significantly as children often suffer from gastrointestinal, allergic, respiratory, and other chronic diseases owing to their lower immunity. The Pediatric Healthcare Market is Segmented by Type (Chronic Illness and Acute Illness), Treatment (Vaccines, Drugs, Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
By Type | |
Chronic Illness | |
Acute Illness |
By Treatment | |
Vaccines | |
Drugs | |
Others |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Pediatric Healthcare Market Size Summary
The pediatric healthcare market is poised for steady growth, driven by an increasing burden of diseases, viral infections, and malnutrition cases. The market experienced a setback during the COVID-19 pandemic due to a decline in pediatric services and the adverse impact on children's health and well-being. However, the resumption of pediatric care services and global vaccination programs have restored the market to its pre-pandemic growth trajectory. Government support and technological advancements further bolster the market, with significant funding initiatives in countries like France and India aimed at enhancing pediatric facilities and services. Despite challenges such as ethical issues in pediatric research and complications associated with pediatric medicines, the market is expected to expand, particularly in the chronic illness segment, due to the rising prevalence of conditions like asthma and obesity among children.
North America is anticipated to hold a significant share of the pediatric healthcare market, driven by a high volume of pediatric cases and the adoption of advanced technologies, especially in the United States. The region's growth is supported by increased government initiatives and funding for pediatric diseases, which are expected to foster the development of new therapies. The market is moderately competitive, with major players like GlaxoSmithKline, Johnson & Johnson, and Pfizer Inc. dominating the landscape. Recent drug approvals and product launches, such as the US FDA's approval of Rethymic for congenital athymia, further contribute to market expansion. The combination of these factors positions the pediatric healthcare market for continued growth over the forecast period.
Pediatric Healthcare Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Burden of Pediatric Diseases
-
1.2.2 Increased R&D Activities and Awareness of Pediatric Medicine Among Public
-
1.2.3 Increasing Availability of Advanced Technologies To Provide Continuous Care
-
-
1.3 Market Restraints
-
1.3.1 Small Size of Study Population and Ethical Issues in Pediatric Research
-
1.3.2 Complications Associated with the Medicines
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Type
-
2.1.1 Chronic Illness
-
2.1.2 Acute Illness
-
-
2.2 By Treatment
-
2.2.1 Vaccines
-
2.2.2 Drugs
-
2.2.3 Others
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Pediatric Healthcare Market Size FAQs
How big is the Pediatric Healthcare Market?
The Pediatric Healthcare Market size is expected to reach USD 15.32 billion in 2024 and grow at a CAGR of 4% to reach USD 18.64 billion by 2029.
What is the current Pediatric Healthcare Market size?
In 2024, the Pediatric Healthcare Market size is expected to reach USD 15.32 billion.